- Home
- WGS
as 11-15-2024 4:00pm EST
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | STAMFORD |
| Market Cap: | 1.5B | IPO Year: | N/A |
| Target Price: | $67.00 | AVG Volume (30 days): | 753.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.29 - $89.11 | Next Earning Date: | 10-29-2024 |
| Revenue: | $267,228,000 | Revenue Growth: | 29.41% |
| Revenue Growth (this year): | 43.7% | Revenue Growth (next year): | 16.78% |
Latest GeneDx Holdings Corp. News
WGS Breaking Stock News: Dive into WGS Ticker-Specific Updates for Smart Investing
Motley Fool
a day ago
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
Barrons.com
a day ago
Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
Barrons.com
9 days ago
Southwest Airlines, Samsara, Nathan’s, and More Stocks See Action From Activist Investors
Business Wire
10 days ago
New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
Zacks
11 days ago
Zacks.com featured highlights include Snap, GeneDx and Leonardo
Zacks
12 days ago
Zacks.com featured highlights include Snap, GeneDx and Leonardo
Business Wire
13 days ago
GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
Zacks
13 days ago
3 Stocks to Buy for Stellar Earnings Acceleration in November
Compare WGS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WGS GeneDx Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.